The Company reaffirmed its outlook for 2024 revenues and Adjusted EBITDA to be greater than $3.075 billion and greater than $508 million, respectively.
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
The Fly
Surgery Partners sees FY24 revenue greater than $3.075B, consensus $3.09B
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App